BioArctic AB (publ) (BRCTF)
OTCMKTS
· Delayed Price · Currency is USD
19.65
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
BioArctic AB Employees
BioArctic AB had 88 employees as of December 31, 2023. The number of employees increased by 27 or 44.26% compared to the previous year.
Employees
88
Change (1Y)
27
Growth (1Y)
44.26%
Revenue / Employee
$158,457
Profits / Employee
-$220,763
Market Cap
1.61B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sandoz Group AG | 22,633 |
| Telix Pharmaceuticals Limited | 234 |
| Elekta AB (publ) | 4,718 |
| Ryman Healthcare Limited | 7,700 |
| Verano Holdings Corp. | 3,900 |
| Vireo Growth Inc. | 490 |
| Medexus Pharmaceuticals Inc. | 82 |
BioArctic AB News
- 21 days ago - Leqembi® approved in Mexico - PRNewsWire
- 4 weeks ago - Leqembi® launched in South Korea - PRNewsWire
- 5 weeks ago - CHMP issues positive recommendation for approval of lecanemab in the EU - PRNewsWire
- 6 weeks ago - Eisai updates Leqembi® outlook for fiscal year 2024 (April 2024 - March 2025). Sales now expected to reach JPY 42.5 billion - PRNewsWire
- 7 weeks ago - Invitation to presentation of BioArctic's third quarter report for July - September 2024 on November 14 at 9.30 a.m. CET - PRNewsWire
- 2 months ago - Lecanemab data presented at CTAD on early initiation and long-term treatment suggest increased patient benefit with maintained safety profile - PRNewsWire
- 2 months ago - Leqembi® revenue totaled JPY 10 billion in the third quarter 2024 - Benzinga
- 2 months ago - Professor Lars Lannfelt, awarded the CTAD Lifetime Achievement Award in recognition for his pioneering work in Alzheimer's Disease - PRNewsWire